Are pharma-doc links necessary or questionable?

Questionable links between doctors and the pharma industry reached their apogee in the U.S. at the start of the millennium, when fierce competition among companies at a time of slowing innovation resulted in the creation of a slew of “me too” drugs, often with little advantage over existing treatment, the Financial Times reports. Report